ResMed CDI (RMD) in Focus: Can the Healthcare Giant Continue to Shine Among ASX 200 Companies?

2 min read | August 27, 2025 05:19 PM AEST | By Team Kalkine Media

ResMed CDI (RMD) in Focus: Can the Healthcare Giant Continue to Shine Among ASX 200 Companies? — Image source: Shutterstock

ResMed CDI and Its Global Footprint

ResMed CDI (ASX:RMD) has established itself as one of the notable ASX 200 companies. Known for its expertise in sleep and respiratory care, the company has built a strong reputation across the healthcare sector. Headquartered in the United States with roots in Australia, it operates on a worldwide scale and serves millions of patients through its advanced medical technologies.

Core Business Segments

ResMed CDI functions through two main divisions – Sleep and Respiratory Care, and Software as a Service (SaaS). The first division provides devices such as continuous positive airway pressure (CPAP) systems and other respiratory equipment. These products address critical health conditions like sleep apnea and chronic respiratory issues.

The SaaS segment supports healthcare providers through digital platforms, enabling smoother patient management and streamlined out-of-hospital care. This mix of hardware and software solutions allows the company to integrate clinical devices with data-driven insights, helping improve patient outcomes and reducing healthcare system burdens.

Financial Perspective

A close look at the financial strength of ResMed CDI reflects consistent revenue growth supported by solid margins. The company’s profitability highlights its ability to balance scale with efficiency. Key measures such as return on equity demonstrate efficient capital deployment, while a healthy balance sheet with manageable debt further enhances resilience.

These financial indicators not only underline the company’s stability but also position it strongly within the competitive healthcare industry. The strength of recurring revenue from SaaS operations also provides an additional layer of long-term stability.

Valuation Considerations

When discussing the valuation of ResMed CDI, it is important to observe trends rather than focus on single-year numbers. Metrics like price-to-sales and historical averages can provide insight into how the market perceives the company over time. In the case of ResMed CDI, steady revenue expansion has helped maintain investor confidence.

Outlook for ResMed CDI

With innovation in medical technology and an expanding global presence, ResMed CDI continues to demonstrate its growth potential. By leveraging connected devices and digital solutions, the company has managed to stay ahead of shifting healthcare demands. Its inclusion among the ASX 200 highlights its standing as a major player in the Australian market while also remaining an international leader in respiratory care.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.